Plantarc Bio Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.235x

Plantarc Bio Ltd cash flow conversion efficiency. Based on the latest financial reports, Plantarc Bio Ltd (PLNT) has a cash flow conversion efficiency ratio of -0.235x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.79 Million ≈ $-4.79K USD) by net assets (ILA7.61 Million ≈ $20.41K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Plantarc Bio Ltd (2018–2024)

Cash flow conversion efficiency of Plantarc Bio Ltd from 2018 to 2024. This chart illustrates how Plantarc Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Plantarc Bio Ltd stock price today for real-time trading data and today's change.

Plantarc Bio Ltd Cash Flow Conversion Ratio Explained

Plantarc Bio Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Plantarc Bio Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Plantarc Bio Ltd ranked by their cash flow conversion efficiency. Also see PLNT market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Lightning Minerals Ltd AU:L1M	-0.316x
WINDELN.DE SE INH O.N. F:WDL1	N/A
Klarsen SA PA:ALKLA	0.061x
Argent Biopharma Ltd AU:RGT	0.379x
Divio Technologies AB Series B ST:DIVIO-B	0.255x
Verney-Carron S.A PA:MLVER	N/A
Olympio Metals Ltd AU:OLY	-2.352x
Totalindo Eka Persada Tbk PT JK:TOPS	-0.009x

Annual Cash Flow Conversion Efficiency for Plantarc Bio Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of Plantarc Bio Ltd from 2018 to 2024. Review PLNT free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA9.53 Million ≈ $25.54K	ILA-1.47 Million ≈ $-3.95K	-0.155x	+43.25%
2023-12-31	ILA11.96 Million ≈ $32.06K	ILA-3.26 Million ≈ $-8.73K	-0.272x	-10.60%
2022-12-31	ILA13.60 Million ≈ $36.46K	ILA-3.35 Million ≈ $-8.98K	-0.246x	-7.68%
2021-12-31	ILA17.72 Million ≈ $47.50K	ILA-4.05 Million ≈ $-10.87K	-0.229x	+84.32%
2020-12-31	ILA1.19 Million ≈ $3.20K	ILA-1.74 Million ≈ $-4.66K	-1.459x	-129.83%
2019-12-31	ILA3.29 Million ≈ $8.82K	ILA-2.09 Million ≈ $-5.60K	-0.635x	+39.03%
2018-12-31	ILA1.70 Million ≈ $4.57K	ILA-1.77 Million ≈ $-4.75K	-1.041x	--

About Plantarc Bio Ltd

TA:PLNT Israel Biotechnology

Market Cap

$1.96 Million

ILA731.02 Million ILA

Market Cap Rank

#30079 Global

#437 in Israel

Share Price

ILA220.90

Change (1 day)

+0.00%

52-Week Range

ILA202.70 - ILA224.40

All Time High

ILA1827.00